Skip to contentD
Decoy Therapeutics Inc.
D
DCOYDecoy Therapeutics Inc. Q2 2025 · 10-Q
Revenue$0.00$0.00no prior Q2 2024 on file Net Income-$957.83K-$957.83KN/M vs Q2 2024 EPS Diluted-$81.21-$81.21N/M vs Q2 2024 Operating Income-$965,565N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
derived
ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d after period end